Inhibition of RACK1 ameliorates choroidal neovascularization formation in vitro and in vivo

详细信息    查看全文

• 作者：Xiaojuan Liu^a ; ^c ; ¹ ; Manhui Zhu^b ; ^c ; ¹ ; Xiaowei Yang^b ; ^c ; Ying Wang^b ; ^c ; Bai Qin^b ; ^c ; Chen Cui^b ; ^c ; Hui Chen^b ; ^c ; ² ; ^{chenhuieye@126.com" class="auth_mail" title="E-mail the corresponding author} ; Aimin Sang^b ; ^c ; ² ; ^{sangam@ntu.edu.cn" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Choroidal neovascularization (CNV) ; Age-related macular degeneration (AMD) ; Receptor for activated C-kinase 1 (RACK1) ; Vascular endothelial growth factor (VEGF)
• 刊名：Experimental and Molecular Pathology
• 出版年：2016
• 出版时间：June 2016
• 年：2016
• 卷：100
• 期：3
• 页码：451-459
• 全文大小：2321 K

文摘

Choroidal neovascularization (CNV) occurs as a result of age-related macular degeneration (AMD) and causes severe vision loss among elderly patients. The receptor for activated C-kinase 1 (RACK1) serves as a scaffold protein which is recently found to promote angiogenesis. However, the impact of RACK1 on the vascular endothelial growth factor (VEGF) expression in endothelial cells and subsequent choroidal angiogenesis formation remains to be elucidated. In this study, we found that RACK1 and VEGF expression increased, and reached the peak at 7 d in mouse CNV model by laser application. Furthermore, on RPE/choroid cryosections, RACK1 co-localized with CD31, suggesting that RACK1 was expressed in endothelial cells. In vitro, RF/6A cell hypoxia model showed that RACK1 expression was up-regulated in parallel with hypoxia-induced factor 1 (HIF-1α) and VEGF expression, reaching the peak at 6 h. Silencing of RACK1 suppressed the invasion and tube formation activity of RF/6A cells in ARPE-19 and RF/6A co-culture system, possibly through VEGF signal pathway. Overexpression of RACK1 showed the opposite effect. Intravitreal injection of anti-RACK1 monoclonal antibody predominantly decreased RACK1 and VEGF expression in mouse laser-induced CNV model. Meanwhile, anti-RACK1 monoclonal antibody intravitreal injection also decreased incidence of CNV and leakage area. These data indicated that RACK1 promoted CNV formation via VEGF pathway. Additionally, anti-RACK1 monoclonal antibody significantly decreased CNV in mouse model and may have therapeutic potential in human CNV.